Sanofi slashes insulin prices to $35 for month supply

Pharmaceutical company Sanofi plans to lower the cost of its 30-day packages of insulin from $99 to $35 for uninsured Americans with diabetes.

Advertisement

“Sanofi believes that people living with diabetes should not face high out-of-pocket costs at the pharmacy counter,” the company said in a June 29 press release. The Paris-based business said the change will be effective July 1.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.